GNI Group Ltd.TSE 2160

株式会社ジーエヌアイグループ · Pharmaceutical · FY ends Dec

Share price at FY-end
¥3,405
FY ending Dec 2025 (approx.)
Market cap at FY-end
¥190B
Dividend per share
—
Avg. director pay
¥7.7M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 CEPLUX-THE INDEPENDENT UCITS PLATFORM2 1,992,500 3.58% ¥6.8B —
2 楽天証券株式会社共有口 1,621,714 2.91% ¥5.5B —
3 株式会社SBI証券 1,221,448 2.19% ¥4.2B —
4 Keiichiro Kinoshita 1,080,000 1.94% ¥3.7B —
5 National Financial Services LLC 1,065,532 1.91% ¥3.6B —
6 PERSHING-DIV.OF DLJSECS.CORP. 820,588 1.47% ¥2.8B —
7 Takuro Ishibashi 683,500 1.23% ¥2.3B —
8 MORGAN STANLEY SMITH BARNEY LLC CLIENTS FULLY PAID SEG ACCOUNT 672,300 1.21% ¥2.3B —
9 日本マスタートラスト信託銀行株式会社 625,600 1.12% ¥2.1B —
10 株式会社日本カストディ銀行 593,400 1.07% ¥2.0B —

Officers' holdings and pay

NameTitleSharesValuePay
イン・ルオ President & Representative Executive Officer, CEO 1,607,700 ¥5.5B ¥140M
松井 亮介 Director, COO, CFO 79,800 ¥272M —
張 平 Director 10,000 ¥34.0M ¥220M
トーマス・イーストリング Director 18,300 ¥62.3M ¥123M
菊池 加奈子 Director — — —
松岡 真宏 Director — — —
矢崎 弘直 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 ¥3,405 ¥-34.71 — — 55,682,069
FY ending Dec 2024 ¥3,405 ¥118.06 28.8x — 50,168,243
FY ending Dec 2023 ¥3,405 ¥-21.92 16.7x — 49,857,243
FY ending Dec 2022 — ¥-25.50 170.1x — 47,487,843
FY ending Dec 2021 — ¥-9.33 65.2x — 47,462,943
Source: annual securities reports on EDINET. Values are estimates. Methodology